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Abstract: The venous thromboembolism and thromboembolic events remain the leading cause of death during pregnancy and post-
partum in developed countries. Recent investigations have provided an important evidence of significantly increased  risk of venous 
thromboembolism after in vitro fertilization (IVF) pregnancies. Nevertheless, there are few case reports showing these emergency 
situations. We report the case of a 40 years old woman, in her twelve week of a twin after IVF pregnancy, who dies after two weeks 
with dizziness, tachycardia and respiratory distress. Our objective is double: to highlight the risks of the pregnancy even in developed 
countries and, on the other hand, to enhance the role of the forensic pathologist and the forensic studies as epidemiological information 
gatherers. 
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Resumen: como es sabido, entre las primeras causas de mortalidad materna durante el embarazo se encuentran los episodios de 
tromboembolismo venoso. Varios  estudios poblacionales ya han demostrado que dicho riesgo se encuentra aumentado de manera muy 
significativa en caso de embarazos logrados mediante técnicas de Fertilización in vitro (FIV). Sin embargo,  apenas existen casos en la 
literatura que ilustren estas situaciones de emergencia. Presentamos el caso de una mujer de 40 años, embarazada de mellizos mediante 
FIV, en su 12ª semana de gestación, que fallece tras dos días con clínica de mareos, taquicardia y ahogos. La finalidad de su publicación 
es doble: por un lado llamar la atención ante uno de los riesgos que acompañan la gestación  y, por otro, poner en valor la función del 
médico forense y el estudio autópsico como fuente de recogida de información de salud pública. 
Palabras clave: Embarazo; fecundación in vitro;  tromboembolismo pulmonar; muerte súbita. 
INTRODUCTION 
Pregnancy and postpartum related death is a global health problem, mainly in developing countries. World Health 
Organization (WHO) estimates 230 maternal deaths per 100.000 live births. The 80% of these deaths are due to serious 
hemorrhages (mainly in the postpartum), infections, arterial hypertension (preeclampsia and eclampsia) and dangerous 
abortions (1).  
In developed countries, the maternal mortality rate decrease to 16 maternal deaths per 100.000 live births. (2). In 
Spain, the Sociedad Española de Ginecología y Obstetricia (SEGO) reviewed the data collected between 2010 and 2012 
and estimated 6 maternal deaths per 100.000 live births, although the underestimation rate is 48%, higher than the 
underestimation rate of France (20%) or EEUU (38%) (2). The main cause of maternal morbidity is the pulmonary 
embolism (PE); the second, gestational hypertension (preeclampsia and eclampsia) (3). Recent studies suggest that risk 
incidence of venous thromboembolism (VTE) considerably increases in after in vitro fertilization (IVF) pregnancies 
(4,5,6,7), due to ovarian hyperstimulation and the pro-coagulation state produced.  
The pulmonary embolism is a clinical emergency, with known signs, symptoms and treatment. Nevertheless, 
these patients survival has not improved in the last years. A quarter of them suffer a sudden death (8), so we must focus 
all the efforts in the prevention and early diagnosis. 
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We report a case of a 40 years old woman, in the first trimester of pregnancy after in vitro fertilization, who 
suddenly died in her house. 
CASE REPORT 
A 40 years old woman died suddenly at home. She was in the 12th week of pregnancy after in vitro fertilization, 
in treatment with Meriestra® 1mg (estradiol) and Progeffik® 200mg (progesterone) until the day before the death. She 
was no resting to prevent a miscarriage. She felt dizziness and tachycardia days before the death, with two intense events 
two days before. She went to her General Practitioner, who studied the arterial pressure (apparently normal) and 
recommended sweet drinks like Coke. The forensic physician couldn´t collect more information about the protocol of 
fertilization or evolution of the pregnancy. 
The external examination of the woman, 158cm high and slim, revealed intense pallor of acral areas and face, lip 
and nail cyanosis, strongly instituted rigor, fixed lividities on lower areas and cervical region and leg-pitting edema at the 
ankles. She had no varicose veins. Internal examination showed a 13x11x4 cm relaxed and flabby gravid uterus, with 4 
leiomyoma and monochorionic biamniotic twin pregnancy, male and female. The ovaries were normal and no thrombi 
were found in the pelvic veins. Congestive lungs with increased weight and multiple thrombi at medium and high diameter 
vessels. Hepatic parenchyma with yellow dots. Thrombosis in the left popliteal vein was revealed. Histopathologically, 
the pulmonary cronic thromboembolic disease was confirmed, with recent and organized thrombi with recanalization at 
small, medium and high diameter vessels, and acute pulmonary edema. (Fig. 1). 
 
Fig.1. 1. Pulmonary thromboembolism. 
Congestive lungs with multiple thrombi at medium and high diameter vessels (a). Pulmonary cronic 
thromboembolic disease (b), with recent and organized thrombi with recanalization (c) at small, medium and high 
diameter vessels, and acute pulmonary oedema. (d). 
The left popliteal vein thrombosis was chronic, with recanalization. (Fig. 2). 
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Fig.2. Left popliteal vein 
Cronic thrombosis with recanalization. Panoramic view (a) and high power view. 
Focal hepatic steatosis and congestion of the zone 3. The examination of the uterus and the fetuses showed 
funiculitis with perivascular damage and acute chorioamnionitis and villitis in both. 
DISCUSSION 
Women in reproductive age have an increased risk of venous thromboembolism (VTE), due to hormonal 
contraception, pregnancy and the profertility ovarian stimulation. All these situations alter the levels of pro-and 
anticoagulants as well the fibrinolytic system.(3,4).  
For a time a similar risk was assumed for natural pregnancies and after in vitro fertilization pregnancies.  However, 
some recent studies reveal a significantly increase of VTE and even pulmonary embolism during the first trimester after 
a IVF pregnancy. In 2012 Rova et al. found a 10-fold increase (100-fold in those pregnancies complicated with an ovarian 
hyperestimulation sindrome, a 6-7% of IVF pregnancies) (5). In 2013, Henriksson et al. reported a 7-fold in increase (6) 
and in 2014 Hansen et al. (7) supported these studies, with no significant differences in single or multiple IVF pregnancies. 
They also revealed an increased risk of VTE during the first 6 weeks post-partum. So, in this group of pregnancies the 
thromboprophylaxis is needed. 
The risk of suffering a pulmonary embolism (PE) after a VTE is well known. Even so, the diagnosis is still difficult 
and nowadays a quarter of patients with PE die with sudden death (5). The suspicious signs (A) and symptoms (B) are 
(8):  
A: dyspnoea, pleuritic pain, pain/ oedema in the legs, hemoptysis, palpitations, chest pain, heart attack.  
B: Tachypnea > 20/min, tachycardia >100/min, crackles, intense S4/S2 cardiac sound, signs related with de 
VTE, temperature > 38º, right “gallop”. 
Our patient felt dyspnoea and palpitations for two weeks, with apparent tachycardia in the two days before death. 
She showed some signs and symptoms of PE, although no evidence of venous thrombosis was clear. Probably these could 
be the reason the general practitioner didn´t suspect the PE. We don´t know if she told him her pregnancy was IVF 
mediated. The fetuses showed signs related with a fetal death (intrauterine), a time before of the mother´s, probably due 
to her cronic thromboembolic disease. 
We have found no other VTE risk factors besides the in vitro fertilization, since the woman was slim, no smoker, 
without varicose veins or ovarian hyperstimulation syndrome´s signs. According to recent studies made by Rova, 
Heriksson and Hansen, in vitro fertilization could be the only risk factor (5,6,7). Even though some cases of VTE after 
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IVF pregnancies have been found in the bibliography reviewed, this is the first sudden death case due to pulmonary 
thromboembolism reported.  
CONCLUSIONS 
As  Christiansen et al. (10) reported and the last SEGO (2) survey has corroborated, it is often difficult to identify 
the maternal deaths in the clinical practice. We must collect all the information about deaths among women of 
reproductive age, pregnancy status at or near the time of death and the medical cause of death. “The forensic works is 
crucial in identifying these cases and elucidating emerging trends” (10). 
The objective of this case report is double: to highlight the risks of  pregnancy even in developed countries and, 
on the other hand, to enhance the role of the forensic physicians and pathologists as epidemiological information gatherers. 
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*Parte de este estudio fue presentado en forma de póster en el III Congreso Nacional de la Sociedad Española de 
Patología Forense, celebrado en Santander los días 20-23 de mayo de 2015. 
 
